CD90 also plays important roles in oncogenesis and shows potential as a candidate marker for cancer stem cells (CSCs) in various malignancies, such as hepatocellular carcinoma (HCC) [8], esophageal cancer [9], and glioma [10]. This evidence concerns the gene THY1 and central nervous system cancer.